• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: 1,5-(Butylimino)-1,5 dideoxy,D-glucitol
Date Designated: 05/12/1998
Orphan Designation: Treatment of Fabry's disease.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Oxford GlycoSciences
10, The Quadrant
Abington Science Park
Abington, Oxfordshire
United Kingdom

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.